Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Comprehensive Transcriptomic and Genomic Profiling of Subtypes of Follicular Variant of Papillary Thyroid Carcinoma.

Song YS, Won JK, Yoo SK, Jung KC, Kim MJ, Kim SJ, Cho SW, Lee KE, Yi KH, Seo JS, Park YJ.

Thyroid. 2018 Oct 16. doi: 10.1089/thy.2018.0198. [Epub ahead of print]

PMID:
30226444
2.

Novel cytomorphologic characteristics suggesting human papillomavirus infection in patients diagnosed as negative for intraepithelial lesion or malignancy and a comparison of diagnostic performance of three human papillomavirus tests.

Jin MS, Lee H, Kim MA, Park IA, Lee C, An HJ, Shim B, Moon JH, Won JK, Ryu HS.

Diagn Cytopathol. 2018 Aug 25. doi: 10.1002/dc.24049. [Epub ahead of print]

PMID:
30144342
3.

Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.

Lee DW, Han SW, Kang JK, Bae JM, Kim HP, Won JK, Jeong SY, Park KJ, Kang GH, Kim TY.

Ann Surg Oncol. 2018 Oct;25(11):3389-3395. doi: 10.1245/s10434-018-6681-5. Epub 2018 Jul 30.

PMID:
30062471
4.

Pheochromocytoma and paraganglioma in Fontan patients: Common more than expected.

Song MK, Kim GB, Bae EJ, Lee YA, Kim HY, Min SK, Kim JH, Won JK.

Congenit Heart Dis. 2018 Jul;13(4):608-616. doi: 10.1111/chd.12625. Epub 2018 Jul 22.

PMID:
30033572
5.

Acute invasive fungal rhinosinusitis: MR imaging features and their impact on prognosis.

Choi YR, Kim JH, Min HS, Won JK, Kim HJ, Yoo RE, Kang KM, Park SW, Yun TJ, Choi SH, Sohn CH, Rhim JH, Kim SC, Ryu JW, Na DG.

Neuroradiology. 2018 Jul;60(7):715-723. doi: 10.1007/s00234-018-2034-0. Epub 2018 May 17.

PMID:
29774383
6.

Recent Advancement of the Molecular Diagnosis in Pediatric Brain Tumor.

Bae JM, Won JK, Park SH.

J Korean Neurosurg Soc. 2018 May;61(3):376-385. doi: 10.3340/jkns.2018.0057. Epub 2018 May 1. Review.

7.

Radiogenomics correlation between MR imaging features and major genetic profiles in glioblastoma.

Hong EK, Choi SH, Shin DJ, Jo SW, Yoo RE, Kang KM, Yun TJ, Kim JH, Sohn CH, Park SH, Won JK, Kim TM, Park CK, Kim IH, Lee ST.

Eur Radiol. 2018 Oct;28(10):4350-4361. doi: 10.1007/s00330-018-5400-8. Epub 2018 May 2.

PMID:
29721688
8.

Asymptomatic intrathyroidal pyriform sinus fistula mimicking thyroid cancer: A case report and literature review.

Kim SC, Kim JH, Won JK, Chung EJ.

Medicine (Baltimore). 2018 Apr;97(16):e0488. doi: 10.1097/MD.0000000000010488.

9.

High-performance and scalable metal-chalcogenide semiconductors and devices via chalco-gel routes.

Kwon SM, Won JK, Jo JW, Kim J, Kim HJ, Kwon HI, Kim J, Ahn S, Kim YH, Lee MJ, Lee HI, Marks TJ, Kim MG, Park SK.

Sci Adv. 2018 Apr 13;4(4):eaap9104. doi: 10.1126/sciadv.aap9104. eCollection 2018 Apr.

10.

Comparison of Immunohistochemistry and Direct Sequencing Methods for Identification of the BRAFV600E Mutation in Papillary Thyroid Carcinoma.

Kim JK, Seong CY, Bae IE, Yi JW, Yu HW, Kim SJ, Won JK, Chai YJ, Choi JY, Lee KE.

Ann Surg Oncol. 2018 Jun;25(6):1775-1781. doi: 10.1245/s10434-018-6460-3. Epub 2018 Apr 2.

PMID:
29611028
11.

An immunohistochemical panel consisting of EZH2, C-KIT, and CD205 is useful for distinguishing thymic squamous cell carcinoma from type B3 thymoma.

Kim BS, Kim JK, Kang CH, Kim YT, Jung KC, Won JK.

Pathol Res Pract. 2018 Mar;214(3):343-349. doi: 10.1016/j.prp.2018.01.009. Epub 2018 Feb 24.

PMID:
29487009
12.

Clinical Characteristics of Subtypes of Follicular Variant Papillary Thyroid Carcinoma.

Kim MJ, Won JK, Jung KC, Kim JH, Cho SW, Park DJ, Park YJ.

Thyroid. 2018 Mar;28(3):311-318. doi: 10.1089/thy.2016.0671. Epub 2018 Feb 16.

PMID:
29343212
13.

Leakage correction improves prognosis prediction of dynamic susceptibility contrast perfusion MRI in primary central nervous system lymphoma.

Kim YS, Choi SH, Yoo RE, Kang KM, Yun TJ, Kim JH, Sohn CH, Park SH, Won JK, Kim TM, Park CK, Kim IH.

Sci Rep. 2018 Jan 11;8(1):456. doi: 10.1038/s41598-017-18901-x.

14.

Droplet digital PCR-based EGFR mutation detection with an internal quality control index to determine the quality of DNA.

Kim SS, Choi HJ, Kim JJ, Kim MS, Lee IS, Byun B, Jia L, Oh MR, Moon Y, Park S, Choi JS, Chae SW, Nam BH, Kim JS, Kim J, Min BS, Lee JS, Won JK, Cho SY, Choi YL, Shin YK.

Sci Rep. 2018 Jan 11;8(1):543. doi: 10.1038/s41598-017-18642-x.

15.

High-Performance Quantum Dot Thin-Film Transistors with Environmentally Benign Surface Functionalization and Robust Defect Passivation.

Jung SM, Kang HL, Won JK, Kim J, Hwang C, Ahn K, Chung I, Ju BK, Kim MG, Park SK.

ACS Appl Mater Interfaces. 2018 Jan 31;10(4):3739-3749. doi: 10.1021/acsami.7b13997. Epub 2018 Jan 22.

PMID:
29322770
16.

Gastrointestinal stromal tumor of unusual phenotype after imatinib treatment: A case report and diagnostic utility of ETV1 mRNA in situ hybridization.

Jung M, Park SH, Jeon YK, Won JK, Yang HK, Kim WH.

Medicine (Baltimore). 2017 Dec;96(49):e9031. doi: 10.1097/MD.0000000000009031.

17.

Differentiation of High-Grade from Low-Grade Astrocytoma: Improvement in Diagnostic Accuracy and Reliability of Pharmacokinetic Parameters from DCE MR Imaging by Using Arterial Input Functions Obtained from DSC MR Imaging.

You SH, Choi SH, Kim TM, Park CK, Park SH, Won JK, Kim IH, Lee ST, Choi HJ, Yoo RE, Kang KM, Yun TJ, Kim JH, Sohn CH.

Radiology. 2018 Mar;286(3):981-991. doi: 10.1148/radiol.2017170764. Epub 2017 Dec 15.

PMID:
29244617
18.

Reclassification of Mixed Oligoastrocytic Tumors Using a Genetically Integrated Diagnostic Approach.

Kim SI, Lee Y, Won JK, Park CK, Choi SH, Park SH.

J Pathol Transl Med. 2018 Jan;52(1):28-36. doi: 10.4132/jptm.2017.09.25. Epub 2017 Sep 29.

19.

Prevention of total thyroidectomy in noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) based on combined interpretation of ultrasonographic and cytopathologic results.

You SH, Lee KE, Yoo RE, Choi HJ, Jung KC, Won JK, Kang KM, Yoon TJ, Choi SH, Sohn CH, Kim JH.

Clin Endocrinol (Oxf). 2018 Jan;88(1):114-122. doi: 10.1111/cen.13473. Epub 2017 Sep 27.

PMID:
28898488
20.

Rare Manifestations of Anaplastic Thyroid Carcinoma: the Role of BRAF Mutation Analysis.

Song YS, Jung CK, Jung KC, Park YJ, Won JK.

J Korean Med Sci. 2017 Oct;32(10):1721-1726. doi: 10.3346/jkms.2017.32.10.1721.

21.

The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas.

Lee Y, Koh J, Kim SI, Won JK, Park CK, Choi SH, Park SH.

Acta Neuropathol Commun. 2017 Aug 29;5(1):62. doi: 10.1186/s40478-017-0465-1.

22.

An Autopsy Proven Child Onset Chronic Traumatic Encephalopathy.

Lee K, Kim SI, Lee Y, Won JK, Park SH.

Exp Neurobiol. 2017 Jun;26(3):172-177. doi: 10.5607/en.2017.26.3.172. Epub 2017 Jun 20.

23.

Comprehensive Modeling of Corneal Alkali Injury in the Rat Eye.

Choi H, Phillips C, Oh JY, Stock EM, Kim DK, Won JK, Fulcher S.

Curr Eye Res. 2017 Oct;42(10):1348-1357. doi: 10.1080/02713683.2017.1317817. Epub 2017 Jun 21.

PMID:
28636415
24.

Good Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel Tests.

Kim J, Park WY, Kim NKD, Jang SJ, Chun SM, Sung CO, Choi J, Ko YH, Choi YL, Shim HS, Won JK; Molecular Pathology Study Group of Korean Society of Pathologists.

J Pathol Transl Med. 2017 May;51(3):191-204. doi: 10.4132/jptm.2017.03.14. Epub 2017 May 10. Review.

25.

Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.

Lee DW, Han SW, Cha Y, Bae JM, Kim HP, Lyu J, Han H, Kim H, Jang H, Bang D, Huh I, Park T, Won JK, Jeong SY, Park KJ, Kang GH, Kim TY.

Cancer. 2017 Sep 15;123(18):3513-3523. doi: 10.1002/cncr.30760. Epub 2017 May 17.

26.

Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma.

Won JK, Yu SJ, Hwang CY, Cho SH, Park SM, Kim K, Choi WM, Cho H, Cho EJ, Lee JH, Lee KB, Kim YJ, Suh KS, Jang JJ, Kim CY, Yoon JH, Cho KH.

Hepatology. 2017 Sep;66(3):855-868. doi: 10.1002/hep.29237. Epub 2017 Jul 20.

PMID:
28439950
27.

Analysis of Fifty Hotspot Mutations of Lung Squamous Cell Carcinoma in Never-smokers.

Lee HY, Lee SH, Won JK, Lee DS, Kwon NJ, Choi SM, Lee J, Lee CH, Lee SM, Yim JJ, Yoo CG, Kim YW, Han SK, Park YS.

J Korean Med Sci. 2017 Mar;32(3):415-420. doi: 10.3346/jkms.2017.32.3.415.

28.

Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study.

Yoo RE, Choi SH, Kim TM, Park CK, Park SH, Won JK, Kim IH, Lee ST, Choi HJ, You SH, Kang KM, Yun TJ, Kim JH, Sohn CH.

Eur Radiol. 2017 Aug;27(8):3156-3166. doi: 10.1007/s00330-016-4692-9. Epub 2016 Dec 14.

PMID:
27975145
29.

A case of recurrent, grade 3 corneal choriostoma after surgical excision.

Kim YJ, Park SY, Won JK, Lee C, Kim J, Yu YS, Oh JY.

J AAPOS. 2017 Feb;21(1):71-73. doi: 10.1016/j.jaapos.2016.08.017. Epub 2016 Nov 16.

PMID:
27866069
30.
31.

Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers.

Yoo SK, Lee S, Kim SJ, Jee HG, Kim BA, Cho H, Song YS, Cho SW, Won JK, Shin JY, Park do J, Kim JI, Lee KE, Park YJ, Seo JS.

PLoS Genet. 2016 Aug 5;12(8):e1006239. doi: 10.1371/journal.pgen.1006239. eCollection 2016 Aug.

32.

Recurrence and Survival After Gross Total Removal of Resectable Undifferentiated or Poorly Differentiated Thyroid Carcinoma.

Lee DY, Won JK, Choi HS, Park do J, Jung KC, Sung MW, Kim KH, Hah JH, Park YJ.

Thyroid. 2016 Sep;26(9):1259-68. doi: 10.1089/thy.2016.0147. Epub 2016 Aug 11.

PMID:
27412715
33.

Antiangiogenic Effect of Bevacizumab: Application of Arterial Spin-Labeling Perfusion MR Imaging in a Rat Glioblastoma Model.

Yun TJ, Cho HR, Choi SH, Kim H, Won JK, Park SW, Kim JH, Sohn CH, Han MH.

AJNR Am J Neuroradiol. 2016 Sep;37(9):1650-6. doi: 10.3174/ajnr.A4800. Epub 2016 May 12.

34.

Ultrasonographic Differentiation Between Nodular Hyperplasia and Neoplastic Follicular-Patterned Lesions of the Thyroid Gland.

Song YS, Kim JH, Na DG, Min HS, Won JK, Yun TJ, Choi SH, Sohn CH.

Ultrasound Med Biol. 2016 Aug;42(8):1816-24. doi: 10.1016/j.ultrasmedbio.2016.03.025. Epub 2016 May 8.

PMID:
27166018
35.

Graves' Patient with Thymic Expression of Thyrotropin Receptors and Dynamic Changes in Thymic Hyperplasia Proportional to Graves' Disease Activity.

Song YS, Won JK, Kim MJ, Lee JH, Kim DW, Chung JK, Park do J, Park YJ.

Yonsei Med J. 2016 May;57(3):795-8. doi: 10.3349/ymj.2016.57.3.795.

36.

Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.

Song YS, Lim JA, Choi H, Won JK, Moon JH, Cho SW, Lee KE, Park YJ, Yi KH, Park DJ, Seo JS.

Cancer. 2016 May 1;122(9):1370-9. doi: 10.1002/cncr.29934. Epub 2016 Mar 11.

37.

Effect of tumor volume on the enhancement pattern of parathyroid adenoma on parathyroid four-dimensional CT.

Lee EK, Yun TJ, Kim JH, Lee KE, Kim SJ, Won JK, Kang KM, Choi SH, Sohn CH.

Neuroradiology. 2016 May;58(5):495-501. doi: 10.1007/s00234-016-1656-3. Epub 2016 Feb 5.

PMID:
26847704
38.

Clinical Implication of Anti-Angiogenic Effect of Regorafenib in Metastatic Colorectal Cancer.

Lim Y, Han SW, Yoon JH, Lee JM, Lee JM, Paeng JC, Won JK, Kang GH, Jeong SY, Park KJ, Lee KH, Kim JH, Kim TY.

PLoS One. 2015 Dec 15;10(12):e0145004. doi: 10.1371/journal.pone.0145004. eCollection 2015.

39.

Factors associated with the sensitivity of fine-needle aspiration cytology for the diagnosis of follicular variant papillary thyroid carcinoma.

Chai YJ, Suh H, Yi JW, Yu HW, Lee JH, Kim SJ, Won JK, Lee KE.

Head Neck. 2016 Apr;38 Suppl 1:E1467-71. doi: 10.1002/hed.24261. Epub 2015 Nov 18.

PMID:
26580475
40.
41.

Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.

Lee DY, Won JK, Lee SH, Park DJ, Jung KC, Sung MW, Wu HG, Kim KH, Park YJ, Hah JH.

Thyroid. 2016 Mar;26(3):404-13. doi: 10.1089/thy.2015.0316. Epub 2015 Dec 14.

PMID:
26541309
42.

Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.

Sunwoo L, Choi SH, Yoo RE, Kang KM, Yun TJ, Kim TM, Lee SH, Park CK, Kim JH, Park SW, Sohn CH, Won JK, Park SH, Kim IH.

Neuroradiology. 2015 Nov;57(11):1111-20. doi: 10.1007/s00234-015-1569-6. Epub 2015 Aug 1.

PMID:
26232204
43.

Usefulness of core needle biopsy for thyroid nodules with macrocalcifications: comparison with fine-needle aspiration.

Yi KS, Kim JH, Na DG, Seo H, Min HS, Won JK, Yun TJ, Ryoo I, Kim SC, Choi SH, Sohn CH.

Thyroid. 2015 Jun;25(6):657-64. doi: 10.1089/thy.2014.0596. Epub 2015 May 5.

44.
45.

Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer.

Park G, Kim TH, Lee HO, Lim JA, Won JK, Min HS, Lee KE, Park DJ, Park YJ, Park WY.

Endocr Relat Cancer. 2015 Feb;22(1):55-63. doi: 10.1530/ERC-14-0467.

PMID:
25527510
46.

Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor.

Won JK, Keam B, Koh J, Cho HJ, Jeon YK, Kim TM, Lee SH, Lee DS, Kim DW, Chung DH.

Ann Oncol. 2015 Feb;26(2):348-54. doi: 10.1093/annonc/mdu530. Epub 2014 Nov 17.

PMID:
25403583
47.

The Frequency and Clinical Implications of the BRAF(V600E) Mutation in Papillary Thyroid Cancer Patients in Korea Over the Past Two Decades.

Hong AR, Lim JA, Kim TH, Choi HS, Yoo WS, Min HS, Won JK, Lee KE, Jung KC, Park DJ, Park YJ.

Endocrinol Metab (Seoul). 2014 Dec 29;29(4):505-13. doi: 10.3803/EnM.2014.29.4.505. Epub 2014 Jul 2.

48.
49.

A novel prognostic factor for hepatocellular carcinoma: protein disulfide isomerase.

Yu SJ, Won JK, Ryu HS, Choi WM, Cho H, Cho EJ, Lee JH, Kim YJ, Suh KS, Jang JJ, Kim CY, Lee HS, Yoon JH, Cho KH.

Korean J Intern Med. 2014 Sep;29(5):580-7. doi: 10.3904/kjim.2014.29.5.580. Epub 2014 Aug 28.

50.

Magnetic resonance imaging diagnosis of metastatic lymph nodes in a rabbit model: efficacy of PJY10, a new ultrasmall superparamagnetic iron oxide agent, with monodisperse iron oxide core and multiple-interaction ligands.

Yoo RE, Choi SH, Cho HR, Jeon BS, Kwon E, Kim EG, Park J, Myeong WJ, Won JK, Lee YS, Kim JH, Park SW, Sohn CH.

PLoS One. 2014 Sep 12;9(9):e107583. doi: 10.1371/journal.pone.0107583. eCollection 2014.

Supplemental Content

Support Center